Selected article for: "SARS case and worldwide pandemic"

Author: John Hann, Angus; Lembach, Hanns; McKay, Siobhan C.; Perrin, Moira; Isaac, John; Oo, Ye H.; Mutimer, David; Mirza, Darius F.; Hartog, Hermien; Perera, Thamara
Title: Controversies regarding shielding and susceptibility to COVID‐19 disease in liver transplant recipients in the United Kingdom
  • Cord-id: 0n9xxa9h
  • Document date: 2020_6_17
  • ID: 0n9xxa9h
    Snippet: December 2019 saw the emergence of a novel coronavirus, SARS-CoV-2, which rapidly escalated to a global pandemic 1 , with an unprecedented impact on healthcare systems worldwide. The objective of this case series is to report on SARS-CoV-2 infection in liver transplant recipients and discuss the role of immunosuppression, comorbidities and shielding. In the UK, transplant recipients were classified as individuals vulnerable to SARS-CoV-2 infection due to immunosuppression. They were advised in l
    Document: December 2019 saw the emergence of a novel coronavirus, SARS-CoV-2, which rapidly escalated to a global pandemic 1 , with an unprecedented impact on healthcare systems worldwide. The objective of this case series is to report on SARS-CoV-2 infection in liver transplant recipients and discuss the role of immunosuppression, comorbidities and shielding. In the UK, transplant recipients were classified as individuals vulnerable to SARS-CoV-2 infection due to immunosuppression. They were advised in late March 2020 (Figure 1) by Public Health England to take additional social distancing precautions, a process referred to as 'shielding' 2 . This is a more rigorous form of isolation that requires the individual to not leave their place of residence or come into contact with others. In essence, completely isolate to minimise the risk of being exposed to SARS-CoV-2.

    Search related documents:
    Co phrase search for related documents
    • acute kidney injury aki and liver transplant: 1
    • acute kidney injury and additional risk: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute kidney injury and liver transplant: 1, 2, 3, 4, 5, 6
    • additional risk and liver transplant: 1